Brief: Shanghai Haohai Biological Technology Sees H1 Net Profit Up 699.2-808.2% Y/Y
June 25 (Reuters) - Shanghai Haohai Biological Technology Co
Ltd 688366.SS :
* SAYS IT SEES H1 NET PROFIT UP 699.2-808.2% Y/Y VERSUS 27.5
MILLION YUAN ($4.26 million) YEAR EARLIER
Source text in Chinese: https://bit.ly/3x9651H
Further company coverage: 688366.SS 6826.HK
($1 = 6.4518 Chinese yuan renminbi)
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.